Literature DB >> 22737277

Bone lesions in recurrent glucagonoma: A case report and review of literature.

Cristian Ghetie1, Daniel Cornfeld, Vassilios S Ramfidis, Kostas N Syrigos, Muhammad W Saif.   

Abstract

Glucagonomas are rare neuroendocrine tumors that arise from α cells of the pancreatic islets. Most of them are malignant and usually present as metastatic disease. Sites most commonly involved in metastases are the liver and regional lymph nodes. Bone metastases are rare events and only a few cases have been reported in the literature. We present the case of a 53-year-old male with a medical history of recurrent non-functioning glucagonoma. He presented 17 years after the initial diagnosis with new blastic bone lesions involving the T1 vertebra and the sacrum. Diagnostic steps and medical management in metastatic glucagonoma are also reviewed.

Entities:  

Keywords:  Blastic lesion; Bone metastases; Glucagonoma; Octreoscan

Year:  2012        PMID: 22737277      PMCID: PMC3382662          DOI: 10.4251/wjgo.v4.i6.152

Source DB:  PubMed          Journal:  World J Gastrointest Oncol


  24 in total

1.  Glucagon expression in cystic pancreatic neuroendocrine neoplasms: an immunohistochemical analysis.

Authors:  Björn Konukiewitz; Tetsuji Enosawa; Günter Klöppel
Journal:  Virchows Arch       Date:  2010-10-05       Impact factor: 4.064

2.  Current imaging and possible therapeutic management of glucagonoma tumors: a case report.

Authors:  D S Johnson; M N Coel; M Bornemann
Journal:  Clin Nucl Med       Date:  2000-02       Impact factor: 7.794

Review 3.  Rare neuroendocrine tumors of the pancreas.

Authors:  Shih-Ping Cheng; Gerard M Doherty
Journal:  Cancer Treat Res       Date:  2010

4.  A glucagon-secreting pancreatic alpha islet cell tumor presenting as spinal cord compression.

Authors:  E D Staren; G A Steinecker; V E Gould
Journal:  J Surg Oncol       Date:  1987-08       Impact factor: 3.454

Review 5.  Neuroendocrine tumors of the gastrointestinal tract: recent advances in molecular genetics, diagnosis, and treatment.

Authors:  Kjell Oberg
Journal:  Curr Opin Oncol       Date:  2005-07       Impact factor: 3.645

Review 6.  Functioning and nonfunctioning neuroendocrine tumors of the pancreas.

Authors:  Elijah Dixon; Janice L Pasieka
Journal:  Curr Opin Oncol       Date:  2007-01       Impact factor: 3.645

Review 7.  Pancreatic neuroendocrine tumours.

Authors:  H L O'Grady; K C Conlon
Journal:  Eur J Surg Oncol       Date:  2007-10-29       Impact factor: 4.424

8.  Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases.

Authors:  Julie King; Richard Quinn; Derek M Glenn; Julia Janssen; Denise Tong; Winston Liaw; David L Morris
Journal:  Cancer       Date:  2008-09-01       Impact factor: 6.860

Review 9.  Neuroendocrine tumors of the pancreas.

Authors:  Jacek Dadan; Piotr Wojskowicz; Agnieszka Wojskowicz
Journal:  Wiad Lek       Date:  2008

10.  Is laparoscopic resection adequate in patients with neuroendocrine pancreatic tumors?

Authors:  Laureano Fernández-Cruz; Laia Blanco; Rebeca Cosa; Héctor Rendón
Journal:  World J Surg       Date:  2008-05       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.